big pharma

The Rumble From the People Can Work

Jan 2, 2016
With press report after press report documenting how big business stiffs millions of its consumers and workers, why is it that more of these victims do not externalize some of their inner agonies by channeling them into civic outrage?
Join our newsletter Stay up to date with the latest from Truthdig. Join the Truthdig Newsletter for our latest publications.

A Solution We Didn’t Know We Needed: Now You Can Bequeath Your Tattoos

Sep 24, 2015
If you have a tattoo, you no longer have to worry about it dying out with your body, thanks to a new service; a piece explains why we're unable to keep pharmaceutical companies from charging absurd amounts for drugs; meanwhile, a year after the Ayotzinapa disappearances in Mexico, relatives of the missing students are still seeking justice. These discoveries and more after the jump.

CEO Who Raised HIV Drug Price by 5,000% Also Hiked Cost of Pill for Children With Incurable Disease

Sep 23, 2015
Pharmaceuticals CEO Martin Shkreli is being called the most hated man in America for raising the price of the HIV drug Daraprim from $13.50 to $750 per pill. Now his earlier pricing decisions are being examined. It is being reported that one such decision led to a 2,000 percent price increase for a medication taken by children suffering from a rare kidney disease.

VIDEO: Turing Pharmaceuticals CEO Martin Shkreli: 5,000 Percent Price Boost ‘Not Excessive at All’

Sep 23, 2015
In case you hadn't heard, last month, Turing Pharmaceuticals CEO and former hedge fund manager Martin Shkreli got hold of the rights to parasite-zapping drug Daraprim, and then he had the bright idea to raise the price from $13.50 to $750 per pill. Now he has a big public relations problem and a self-created health care crisis on his hands.